Cancer Research KI News
Research News

Summer 2022


Read the newsletter in your browser

Tell a colleague about this newsletter

Read the newsletter in your browser

Cancer Research KI updates and upcoming events


Awardees of the 2022 Mayo Clinic and Karolinska Institutet Collaborative Cancer Research Program


Congratulations to five KI researchers that have been awarded Mayo Clinic and Karolinska Institutet Collaborative Cancer Research grants.

Galina Selivanova, Professor of Cell and Tumor Biology, Karolinska Institutet and Keith Knutson, Professor of Immunology, Mayo Clinic Florida for a project entitled “Mutant p53 as a target to improve response to immune checkpoint blockade”

Klas Wiman, Professor of Molecular Cell and Tumor Biology, Karolinska Institutet and Mrinal Patnaik, M.B.B.S., Associate Professor of Medicine, Mayo Clinic Rochester for a project “Pseudo-Mutant p53: a Predictor of Leukemic Transformation in Clonal Hematopoiesis”

Mikael Eriksson, PhD, Karolinska Institutet and Celine Vachon, Professor of Epidemiology, Mayo Clinic Rochester for a project entitled “Artificial intelligence image-based model development and validation for long-term breast cancer risk assessment in Swedish and U.S. screening setting”

Qiang Pan-Hammarström, Professor of Clinical Immunology, Karolinska Institutet and Zhi Zhang Yang, M.D., Assistant Professor of Medicine, Mayo Clinic Rochester for a project entitled “Development of targeted immunotherapy for malignant B cell lymphomas”

Richard Rosenquist Brandell, Professor of Clinical Genetics, Karolinska Institutet and Neil Kay, M.D., Professor of Medicine, Mayo Clinic for a project entitled "Multi-Omics Studies of BTK Inhibitor Resistance in Chronic Lymphocytic Leukemia”

Also, two projects awarded in 2021 were extended for the second year of funding for their collaborative breast cancer research projects.

Urban Lendahl, Professor of Genetics, and Antonio D’Assoro, M.D., Associate Professor of Pharmacology, “Novel NOTCH3-Based Therapies to Inhibit the Growth and Immune Evasion Capacity of Triple-Negative Breast Cancer”

Arne Östman, Professor in Molecular Oncology and Derek Radisky, Professor of Cancer Biology, “Exploration of fibroblasts as biologically relevant biomarkers in breast benign disease”

Learn more about the grant.

Save the date: November 16, 2022

En dag för cancerforskning Karolinska Institutet


Save the date: May 16-17, 2023

6th Swedish Cancer Research Meeting


The meeting is open to all clinical, preclinical researchers and others with an interest in cancer research from the organizing universities.

Venue: Karolinska Institutet, Aula Medica, Erling Persson-salen salen, Nobels väg 6, 171 65 Solna

Host: Cancer Research KI

Organizers:U-CAN from Uppsala/Umeå Universities, LUCC (Lund University Cancer Centre), University of Gothenburg, and Cancer Research KI from Karolinska Institutet.

Seminars and Workshops


Karolinska Hematology Seminar XX September 8-9, 2022 at Steningevik

The seminar is a two-day meeting with the aim of offering State of the Art lectures by internationally leading experts in selected hematological areas. The lectures are followed by interesting discussions and exchanges of experience between participants and lecturers.

The registration by August 2, 2022 at the latest.

For questions: e-mail: and contact: Magnus Björkholm Karolinska University Hospital Solna

Organisation European Cancer Institutes (OECI) Oncology Days in Valencia


During the 44th OECI Oncology Days in Valencia, Spain, Karolinska Comprehensive Cancer Centre (Karolinska CCC) received the certificate two years after the Comprehensive Cancer Center. The “OECI Oncology Days 2022” covers a series of current topics in oncology. The three conference days include: a first day dedicated to updating the activities of the OECI working groups (WG); a second day focused on the Scientific Conference presenting the topic of “Artificial intelligence: a tool in modern and future oncology” as a resource with great potential that should be incorporated into our cancer centres; and finally, the third day will be devoted to the OECI General Assembly. During the meeting, Karolinska CCC presented the model of patient involvement 2.0 and the role of the contact nurse.

Glad midsommar!

Cancer Research KI wishes all Glad midsommar and happy holidays. We hope to see you back in August when new calls, events and other possibilities will be announced. Stay tuned!

Recent Research Publications


Lars Björnebo (Dept. of Medical Epidemiology and Biostatistics) et al., "Association of 5α-Reductase Inhibitors With Prostate Cancer Mortality". JAMA Oncol, May 2022.

Huan Cai (Center for Hematology and Regenerative Medicine, Department of Medicine Huddinge) et al., "Critical Role of Lama4 for Hematopoiesis Regeneration and Acute Myeloid Leukemia Progression." Blood, May 2022.

Mikael Eriksson (Dept. of Medical Epidemiology and Biostatistics) et al., "A risk model for digital breast tomosynthesis to predict breast cancer and guide clinical care". Sci Transl Med May 2022.

Erwei Zeng (Dept. of Medical Epidemiology and Biostatistics) et al., "Adjuvant Hormone Therapy-Related Hot Flashes Predict Treatment Discontinuation and Worse Breast Cancer Prognosis". J Natl Compr Canc Netw, April 2022.

Any cancer-related publications from a KI-based researcher (corresponding author must be from KI) that you wish to be advertised through our newsletter please send in the format shown above to our email:

Open Positions


Please send us your open positions for Master projects, PhD candidates and postdocs so that we can advertise them to our Cancer Research KI community.

Facebook Twitter Cancer Research KI Homepage

Cancer Research KI is an overarching umbrella organisation and single point of entry to cancer research at Karolinska Institutet, conducted by some 350 research groups at multiple campuses and departments. The aim is to combine cancer research with clinical oncology by bringing together top level cancer scientists from different disciplines, with the overall goal to generate new scientific discoveries that can be rapidly translated into clinical practice for the benefit of patients and society.


Do not click this link